Navigation help for breast cancer patients with social needs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses a patient navigator system to identify social stressors that may create barriers to care for individuals with breast cancer. Navigators link patients to community resources to address unmet social needs. Eligible participants are adults with breast cancer being treated at the Siteman Cancer Center who speak English and consent to navigation services. The program does not involve a traditional drug or procedure trial, and there is no listed phase. Outcomes focus on barriers to care and resource connections rather than a pharmacologic intervention.

Why it matters

Who can join: the full rules

Eligibility Criteria:

* Diagnosed with breast cancer (any stage).
* Currently being treated for breast cancer by a breast medical oncologist at Siteman Cancer Center North County. This includes any treatment, PO or IV, including hormonal therapy. It does not include patients enrolled in clinical trials.
* At least 18 years of age.
* English-speaker.
* Verbally consented to navigation services.

Where it's running

• Washington University School of Medicine
  St Louis, Missouri, United States Recruiting

Study contacts

• Principal investigator: Emily L Podany, MD, MPHS — Washington University School of Medicine
• Study coordinator: Emily L Podany, MD, MPHS
• Email: elpodany@wustl.edu
• Phone: 314-273-4474

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endocrine therapy for older women with operable breast cancer

  This study is testing if hormone therapy alone can effectively treat older women with early-stage breast cancer, so they might not need extra treatments.

  Recruiting Phase 2 Washington University School of Medicine · St Louis, Missouri · NCT02476786

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.